Dr. Martin Lévesque, PhD, is a professor at Laval University and the director of the Integrative Neuroscience and Experimental Therapies at CERVO Brain Research Centre. With expertise in brain circuits development and the neurobiology of Parkinson's disease (PD), he has made significant contributions to the field. Dr Lévesque obtained his MSc and PhD in neurobiology at Laval University and pursued postdoctoral training at the Montreal Clinical Research Institute (Canada) and at the National Institute for Medical Research in London (UK). Through his research, Dr. Lévesque strives to advance our understanding of brain function and elucidating the mechanisms underlying neuron degeneration. His research on PD focuses on biomarker discovery for early disease diagnosis, novel therapies against neurodegeneration and the advancement of efficient cell replacement therapy for regenerating neuronal circuits from stem cells.
Associated Grants
-
Using a Virally Encoded, Single-chain Antibody as a Noninvasive Gene Therapy for Parkinson’s Disease
2023
-
Antibodies Blocking Alpha-synuclein Toxicity and Spread for the Treatment of Parkinson’s Disease
2019
-
Transcription Factors as Key Targets to Regulate The Selective Vulnerability of Dopamine Neurons
2015